BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States. more
| Time Frame | BME | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 0.86% | -0.81% | 1.06% |
| 1-Month Return | 1.55% | -0.94% | 5.25% |
| 3-Month Return | -6.13% | 0.25% | 10.46% |
| 6-Month Return | -2.51% | -2.76% | 11.48% |
| 1-Year Return | 10.5% | 0.88% | 27.97% |
| 3-Year Return | -0.1% | 60.22% | 79.92% |
| 5-Year Return | -15.61% | 34.56% | 80.73% |
| 10-Year Return | 8.4% | 166.01% | 261.48% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 59.66M | (25.97M) | 34.90M | 24.07M | 36.16M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-43.53,"profit":false},{"date":"2023-12-31","value":58.49,"profit":true},{"date":"2024-12-31","value":40.35,"profit":true},{"date":"2025-12-31","value":60.61,"profit":true}] |
| Cost of Revenue | 6.11M | 5.94M | 6.02M | 78.00 | 5.63M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.25,"profit":true},{"date":"2023-12-31","value":98.54,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":92.08,"profit":true}] |
| Gross Profit | 59.66M | (25.97M) | 28.87M | 24.07M | 30.53M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-43.53,"profit":false},{"date":"2023-12-31","value":48.4,"profit":true},{"date":"2024-12-31","value":40.35,"profit":true},{"date":"2025-12-31","value":51.18,"profit":true}] |
| Gross Margin | 100.00% | 100.00% | 82.75% | 100.00% | 84.44% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.75,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":84.44,"profit":true}] |
| Operating Expenses | 541.46K | 500.13K | 393.60K | 617.09K | (46.46M) | [{"date":"2021-12-31","value":87.74,"profit":true},{"date":"2022-12-31","value":81.05,"profit":true},{"date":"2023-12-31","value":63.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-7529.52,"profit":false}] |
| Operating Income | 59.12M | (26.47M) | 8.46M | 23.45M | 77.00M | [{"date":"2021-12-31","value":76.78,"profit":true},{"date":"2022-12-31","value":-34.38,"profit":false},{"date":"2023-12-31","value":10.99,"profit":true},{"date":"2024-12-31","value":30.46,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | - | - | 11.55M | 70.36M | (27.78K) | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":16.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-0.04,"profit":false}] |
| Pre-Tax Income | 59.12M | (26.47M) | 20.02M | 23.45M | 76.97M | [{"date":"2021-12-31","value":76.81,"profit":true},{"date":"2022-12-31","value":-34.39,"profit":false},{"date":"2023-12-31","value":26.01,"profit":true},{"date":"2024-12-31","value":30.47,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income Taxes | 12.11K | 1.53M | 2.01M | - | - | [{"date":"2021-12-31","value":0.6,"profit":true},{"date":"2022-12-31","value":76.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income After Taxes | - | - | 18.01M | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 59.12M | (26.47M) | 20.02M | 23.45M | 76.97M | [{"date":"2021-12-31","value":76.81,"profit":true},{"date":"2022-12-31","value":-34.39,"profit":false},{"date":"2023-12-31","value":26.01,"profit":true},{"date":"2024-12-31","value":30.47,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 59.12M | (26.47M) | 20.02M | 23.45M | 76.97M | [{"date":"2021-12-31","value":76.81,"profit":true},{"date":"2022-12-31","value":-34.39,"profit":false},{"date":"2023-12-31","value":26.01,"profit":true},{"date":"2024-12-31","value":30.47,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | 14.86 | (5.29) | - | 0.73 | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-35.59,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":4.91,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BME | |
|---|---|
| ROA (LTM) | 0.19% |
| ROE (LTM) | 13.81% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| BME | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.00 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 1.00 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BME | |
|---|---|
| Trailing PE | 6.76 |
| Forward PE | NM |
| P/S (TTM) | 66.83 |
| P/B | 0.91 |
| Price/FCF | NM |
| EV/R | 6.67 |
| EV/Ebitda | NM |
| PEG | NM |
BlackRock Health Sciences Trust (BME) share price today is $39.49
Yes, Indians can buy shares of BlackRock Health Sciences Trust (BME) on Vested. To buy
Yes, you can purchase fractional shares of BlackRock Health Sciences Trust (BME) via the Vested app. You can start investing in BlackRock Health Sciences Trust (BME) with a minimum investment of $1.
You can invest in shares of BlackRock Health Sciences Trust (BME) via Vested in three simple steps:
The 52-week high price of BlackRock Health Sciences Trust (BME) is $41.91. The 52-week low price of BlackRock Health Sciences Trust (BME) is $32.77.
The price-to-earnings (P/E) ratio of BlackRock Health Sciences Trust (BME) is
The price-to-book (P/B) ratio of BlackRock Health Sciences Trust (BME) is 0.91
The dividend yield of BlackRock Health Sciences Trust (BME) is 7.82%
The market capitalization of BlackRock Health Sciences Trust (BME) is
The stock symbol (or ticker) of BlackRock Health Sciences Trust is BME
Consider the share price of BlackRock Health Sciences Trust as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether BlackRock Health Sciences Trust has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in BlackRock Health Sciences Trust shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the BlackRock Health Sciences Trust stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of BlackRock Health Sciences Trust and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that BlackRock Health Sciences Trust stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied
